These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8426017

  • 1. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK, Hoff PT, Homeister JW, Fantone JC, Lucchesi BR.
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
    Mickelson JK, Simpson PJ, Lucchesi BR.
    J Mol Cell Cardiol; 1989 Apr; 21(4):393-405. PubMed ID: 2746660
    [Abstract] [Full Text] [Related]

  • 3. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG, Sill JC, Berger I, Folts JD, Milde JH.
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [Abstract] [Full Text] [Related]

  • 4. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP, Sakariassen KS, Turitto VT, Baumgartner HR.
    Arterioscler Thromb; 1991 Apr; 11(5):1182-91. PubMed ID: 1911705
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
    Mickelson JK, Simpson PJ, Cronin M, Homeister JW, Laywell E, Kitzen J, Lucchesi BR.
    Circulation; 1990 Feb; 81(2):617-27. PubMed ID: 2105175
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459.
    Mousa SA, Kapil R, Mu DX.
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2535-41. PubMed ID: 10521384
    [Abstract] [Full Text] [Related]

  • 8. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT.
    J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
    [Abstract] [Full Text] [Related]

  • 9. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
    Nicolini FA, Nichols WW, Saldeen TG, Mehta JL.
    Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
    [Abstract] [Full Text] [Related]

  • 10. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD, Müller TH.
    Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
    [Abstract] [Full Text] [Related]

  • 11. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
    Keller JW, Folts JD.
    Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
    [Abstract] [Full Text] [Related]

  • 12. Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary artery.
    Mehta JL, Chen L, Nichols WW, Mattsson C, Gustafsson D, Saldeen TG.
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):345-51. PubMed ID: 9514177
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 14. Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury.
    Rubenstein MH, Finn AV, Leinbach RC, Hollenbach S, Aretz HT, Virmani R, Gold HK.
    J Am Coll Cardiol; 2004 Jan 21; 43(2):287-94. PubMed ID: 14736451
    [Abstract] [Full Text] [Related]

  • 15. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, McNatt J, Buja LM, Condorelli M, Chiariello M.
    Circulation; 1993 Sep 21; 88(3):1205-14. PubMed ID: 8353882
    [Abstract] [Full Text] [Related]

  • 16. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B, Horstick G, Berg O, Heimann A, Münzel T, Vahl CF, Kempski O, Darius H.
    Thromb Haemost; 2006 Feb 21; 95(2):354-61. PubMed ID: 16502561
    [Abstract] [Full Text] [Related]

  • 17. Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog.
    Cousins GR, Friedrichs GS, Sudo Y, Rebello SS, Rote WE, Vlasuk GP, Nolan TG, Mendoza C, Lucchesi BR.
    Circulation; 1996 Oct 01; 94(7):1705-12. PubMed ID: 8840864
    [Abstract] [Full Text] [Related]

  • 18. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY, Nichols WW, Mattsson C, Teger-Nilson AC, Wallin R, Saldeen TG, Mehta JL.
    Cardiovasc Res; 1995 Dec 01; 30(6):866-74. PubMed ID: 8746200
    [Abstract] [Full Text] [Related]

  • 19. Prevention by DV-7028, a selective 5-HT2 receptor antagonist, of the formation of coronary thrombi in dogs.
    Morishima Y, Tanaka T, Watanabe K, Igarashi T, Yasuoka M, Shibano T.
    Cardiovasc Res; 1991 Sep 01; 25(9):727-30. PubMed ID: 1799906
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K, Zhou X, Huang Y, Khalil M, Wiktor D, van Giezen JJ, Penn MS.
    Thromb Haemost; 2010 Sep 01; 104(3):609-17. PubMed ID: 20694285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.